OBJECTIVE -Triglyceride-rich lipoprotein particles may promote the progression of diabetic nephropathy. Patients with diabetic nephropathy have increased plasma triglycerides and reduced activity of hepatic lipase (HL), which hydrolyzes triglycerides. We hypothesized that the HL Ϫ514C3 T polymorphism, which reduces HL expression, and its interactions with polymorphisms in apolipoprotein (apo) E and apoC3 increase the risk of diabetic nephropathy.
RESEARCH DESIGN AND METHODS-In a case-control study involving 374 Chinese type 2 diabetic patients with and 392 without diabetic nephropathy, we genotyped the HL Ϫ514C3 T, apoE exon 4, and apoC3 Ϫ482C3 T polymorphisms.RESULTS -HL Ϫ514TϪcontaining genotypes (Tϩ) were associated with diabetic nephropathy (OR ϭ 1.7, P ϭ 0.0009). Adjustment by multiple logistic regression for hypertension, triglycerides, sex, non-HDL cholesterol, BMI, smoking, and alcohol intake did not diminish the association (OR ϭ 1.8, P ϭ 0.003). The association between HL Tϩ genotypes and diabetic nephropathy appeared stronger in diabetic patients with apoC3 Ϫ482 non-TT genotypes (OR ϭ 1.9, P ϭ 0.003) or apoE ε2 or ε4 alleles (OR ϭ 2.2, P ϭ 0.005). Subjects with HL TT exhibited trends toward increased triglyceride and non-HDL cholesterol levels compared with CC carriers.CONCLUSIONS -HL Tϩ genotypes might increase the risk of developing diabetic nephropathy by slowing clearance of triglyceride-rich remnant lipoproteins. In concert with other risk factors (e.g., hyperglycemia), lipid abnormalities may damage the kidneys and endothelium, where reduced binding sites for lipases may precipitate a vicious cycle of dyslipidemia, proteinuria, and nephropathy.
Diabetes Care 28:1704 -1709, 2005D iabetic nephropathy is a major cause of end-stage renal disease. Epidemiological and family-based studies suggest there is a genetic predisposition to diabetic nephropathy (1). Identifying the genetic risk factors for diabetic nephropathy may allow vulnerable type 2 diabetic patients to be screened for the disease and preventive treatment to be developed; in addition, elucidating the pathogenesis of the disease may aid in the design of better treatment.There is evidence to suggest that triglyceride-rich lipoprotein particles containing predominantly apolipoproteins (apos) E, C, and B may be major promoters of diabetic nephropathy (2,3). In diabetic nephropathy patients, the increase in plasma triglycerides may in part be due to reduced activity of hepatic lipase (HL), which hydrolyzes triglycerides (4). The HL promoter polymorphism Ϫ514C3 T, alternatively named Ϫ480C3 T, belongs to a haplotype that alters HL expression (5). Interactions among HL Ϫ514C3 T, apoE exon 4, and apoC3 Ϫ482C3 T polymorphisms in patients with youngonset type 2 diabetes or cardiovascular diseases have been reported (6,7). Given the importance of lipid metabolism in these related diseases, we hypothesized that HL Ϫ514C3 T may interact with apoE and apoC polymorphisms to induce nephropathy in diabetic patients. We tested this hypothesis in a large c...